Article

Temporary 'Doc Fix' Agreement Reached, Boehner Says

Another temporary 12-month patch will be enacted for the doc fix prior to the scheduled March 31 expiration of the current patch, House Speaker John Boehner (R-Ohio) indicated Wednesday.

Another temporary 12-month patch will be enacted for the “doc fix” prior to the scheduled March 31 expiration of the current patch, House Speaker John Boehner (R-Ohio) indicated Wednesday.

There will be no permanent doc fix prior to the deadline, because House and Senate leaders still haven't settled on how to pay for permanent repeal and replacement of Medicare's unpopular sustainable growth-rate formula for physician payment. Boehner said he has instead worked out a deal with Senate Majority Leader Harry Reid (D-Nev.) on a 12-month patch in order to avoid a 24% reduction in payments to doctors who treat Medicare beneficiaries

Read the full story here: http://bit.ly/1o1pCv0

Source: Modern Healthcare

Related Videos
Casey Koch, PharmD, sitting for a video interview
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Related Content
Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com .jpeg
May 1st 2025

Novo Nordisk Expands GLP-1 Access Through Telehealth Providers

Pearl Steinzor
Self-paying patients can now obtain semaglutide at a lower cost through trusted telehealth providers.
managed care cast logo
April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD
On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Prescription drug costs | Image credit: Mark Aplet - stock.adobe.com
May 1st 2025

Drug Affordability Challenges in the “Patient as Payer” Era

Pearl Steinzor
Experts urge for technology-driven, collaborative solutions as patients shoulder a growing burden of prescription costs.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Doctor holding generated image of lungs inside a heart | Image credit: Kiattisak - stock.adobe.com
April 28th 2025

PH, PAH Prevalence Higher in Medicaid, With Racial, Ethnic Disparities

Laura Joszt, MA
Medicaid beneficiaries face higher rates of pulmonary hypertension, with significant economic burdens and racial disparities in prevalence and costs.
glp-1 Wegovy, semaglutide | Image credit: Patrick Bay Damsted - stock.adobe.com
April 25th 2025

Can Medicare Sustain Widespread Access to GLP-1 Therapies?

Skylar Jeremias
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo